SORBS2 and Alzheimer disease: This study provides compelling evidence that the SORBS2 T189M mutation contributes to AD pathology through mechanisms that include enhanced neuroinflammation, synaptic dysfunction, exacerbated Aβ accumulation, and neuronal loss.